Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 986797, 13 pages
http://dx.doi.org/10.1155/2011/986797
Review Article

Immunomodulation of Autoimmune Arthritis by Herbal CAM

1Department of Microbiology and Immunology, University of Maryland School of Medicine, HSF-1, Suite 380, 685 W. Baltimore st., Baltimore, MD 21201, USA
2Center for Integrative Medicine, University of Maryland School of Medicine, East Hall, W. Lombard st., Baltimore, MD 21201, USA

Received 15 April 2010; Accepted 30 September 2010

Copyright © 2011 Shivaprasad H. Venkatesha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. K. Kwoh, R. W. Simms, L. G. Anderson et al., “Guidelines for the management of rheumatoid arthritis: American College of Rheumatology Ad Hoc Committee on Clinical Guidelines,” Arthritis and Rheumatism, vol. 39, no. 5, pp. 713–722, 1996. View at Google Scholar · View at Scopus
  2. L. S. Simon and D. Yocum, “New and future drug therapies for rheumatoid arthritis,” Rheumatology, vol. 39, no. 1, pp. 36–42, 2000. View at Google Scholar · View at Scopus
  3. H. M. Kremers, P. Nicola, C. S. Crowson, W. M. O'Fallon, and S. E. Gabriel, “Therapeutic strategies in rheumatoid arthritis over a 40-year period,” Journal of Rheumatology, vol. 31, no. 12, pp. 2366–2373, 2004. View at Google Scholar · View at Scopus
  4. N. J. Olsen and C. M. Stein, “New Drugs for Rheumatoid Arthritis,” The New England Journal of Medicine, vol. 350, no. 21, pp. 2167–2226, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. P. E. Lipsky, “Rheumatoid arthritis,” in Harrison's Principles of Internal Medicine, D. L. Kasper, E. Braunwald, A. S. Fauci, S. L. Hauser, D. L. Longo, and J. L. Jameson, Eds., pp. 1968–1977, McGraw–Hill, New York, NY, USA, 16th edition, 2005. View at Google Scholar
  6. J. Couzin, “Withdrawal of Vioxx casts a shadow over COX-2 inhibitors,” Science, vol. 306, no. 5695, pp. 384–385, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. P. E. Lipsky and X.-L. Tao, “A potential new treatment for rheumatoid arthritis: thunder god vine,” Seminars in Arthritis and Rheumatism, vol. 26, no. 5, pp. 713–723, 1997. View at Google Scholar · View at Scopus
  8. J. A. Astin, W. Beckner, K. Soeken, M. C. Hochberg, and B. Berman, “Psychological interventions for rheumatoid arthritis: a meta-analysis of randomized controlled trials,” Arthritis Care and Research, vol. 47, no. 3, pp. 291–302, 2002. View at Google Scholar · View at Scopus
  9. J. Cibere, Z. Deng, Y. Lin et al., “A randomized double blind, placebo controlled trial of topical Tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis,” Journal of Rheumatology, vol. 30, no. 3, pp. 465–467, 2003. View at Google Scholar · View at Scopus
  10. D. M. Taibi and C. Bourguignon, “The role of complementary and alternative therapies in managing rheumatoid arthritis,” Family & Community Health, vol. 26, no. 1, pp. 41–52, 2003. View at Google Scholar · View at Scopus
  11. P. M. Barnes, E. Powell-Griner, K. McFann, and R. L. Nahin, “Complementary and alternative medicine use among adults: United States, 2002,” Advance Data, no. 343, pp. 1–19, 2004. View at Google Scholar · View at Scopus
  12. K. L. Soeken, “Selected CAM therapies for arthritis-related pain: the evidence from systematic reviews,” Clinical Journal of Pain, vol. 20, no. 1, pp. 13–18, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Ahmed, J. Anuntiyo, C. J. Malemud, and T. M. Haqqi, “Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 3, pp. 301–308, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. G. G. Zhang, W. Lee, B. Bausell, L. Lao, B. Handwerger, and B. Berman, “Variability in the Traditional Chinese Medicine (TCM) diagnoses and herbal prescriptions provided by three TCM practitioners for 40 patients with rheumatoid arthritis,” Journal of Alternative and Complementary Medicine, vol. 11, no. 3, pp. 415–421, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. J. Gagnier, M. van Tulder, B. Berman, and C. Bombardier, “Herbal medicine for low back pain,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD004504, 2006. View at Google Scholar · View at Scopus
  16. K. Nozaki, H. Hikiami, H. Goto, T. Nakagawa, N. Shibahara, and Y. Shimada, “Keishibukuryogan (Gui-Zhi-Fu-Ling-Wan), a Kampo formula, decreases disease activity and soluble vascular adhesion molecule-1 in patients with rheumatoid arthritis,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 3, pp. 359–364, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Hijikata, Y. Miyamae, H. Takatsu, and S. Sentoh, “Two Kampo medicines, Jidabokuippo and Hachimijiogan alleviate sprains, bruises and arthritis,” Evidence-Based Complementary and Alternative Medicine, vol. 4, no. 4, pp. 463–467, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Khanna, G. Sethi, K. S. Ahn et al., “Natural products as a gold mine for arthritis treatment,” Current Opinion in Pharmacology, vol. 7, no. 3, pp. 344–351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. K. W. Chen, A. Perlman, J. G. Liao, A. Lam, J. Staller, and L. H. Sigal, “Effects of external qigong therapy on osteoarthritis of the knee,” Clinical Rheumatology, vol. 27, no. 12, pp. 1497–1505, 2008. View at Publisher · View at Google Scholar
  20. K. Sengupta, K. V. Alluri, A. R. Satish et al., “A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee,” Arthritis Research and Therapy, vol. 10, no. 4, article R85, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. L. F. Callahan, E. K. Wiley-Exley, T. J. Mielenz et al., “Use of complementary and alternative medicine among patients with arthritis,” Preventing Chronic Disease, vol. 6, no. 2, p. A44, 2009. View at Google Scholar · View at Scopus
  22. Strategic Plan 2005-2009 Draft for Public Comment, National Center for Complementary and Alternative Medicine, National Institute of Health, Bethesda, MD, USA, 2004.
  23. D. M. Eisenberg, R. B. Davis, S. L. Ettner et al., “Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey,” Journal of the American Medical Association, vol. 280, no. 18, pp. 1569–1575, 1998. View at Google Scholar · View at Scopus
  24. G. M. Kuo, S. T. Hawley, L. T. Weiss, R. Balkrishnan, and R. J. Volk, “Factors associated with herbal use among urban multiethnic primary care patients: a cross-sectional survey,” BMC Complementary and Alternative Medicine, vol. 4, article 18, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. N. W. Crawford, D. R. Cincotta, A. Lim, and C. V. E. Powell, “A cross-sectional survey of complementary and alternative medicine use by children and adolescents attending the University Hospital of Wales,” BMC Complementary and Alternative Medicine, vol. 6, article 16, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Manheimer and B. Berman, “NCCAM support for the cochrane collaboration CAM field,” Complementary Therapies in Medicine, vol. 11, no. 4, pp. 268–271, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. E. L. Cooper and S. B. Hecht, “Latin American Center symposium on environment and health: exploring natural products—April 19, 2005, Moss auditorium, room A2-342 Marion Davies Children's Clinic (MDCC) Center for Health Sciences,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 3, pp. 409–410, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. E. L. Cooper, “The immune system and complementary and alternative medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 4, supplement 1, pp. 5–8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. B. M. Berman, B. K. Singh, L. Lao, B. B. Singh, K. S. Ferentz, and S. M. Hartnoll, “Physicians' attitudes toward complementary or alternative medicine: a regional survey,” The Journal of the American Board of Family Practice, vol. 8, no. 5, pp. 361–366, 1995. View at Google Scholar · View at Scopus
  30. E. Ben-Arye, M. Frenkel, A. Klein, and M. Scharf, “Attitudes toward integration of complementary and alternative medicine in primary care: perspectives of patients, physicians and complementary practitioners,” Patient Education and Counseling, vol. 70, no. 3, pp. 395–402, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Desylvia, M. Stuber, C. C. Fung, S. Bazargan-Hejazi, and E. Cooper, “The knowledge, attitudes and usage of complementary and alternative medicine of medical students,” Evidence-Based Complementary and Alternative Medicine. 2008 In press.
  32. N. R. Rose, “Mechanisms of autoimmunity,” Seminars in Liver Disease, vol. 22, no. 4, pp. 387–394, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Z. Atassi and P. Casali, “Molecular mechanisms of autoimmunity,” Autoimmunity, vol. 41, no. 2, pp. 123–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Kasahara and E. L. Cooper, “Nervous, endocrine, immune systems as a target for complementary and alternative medicine,” Advances in Experimental Medicine and Biology, vol. 546, pp. 405–423, 2004. View at Google Scholar · View at Scopus
  35. C. Franceschi, “Inflammaging as a major characteristic of old people: can it be prevented or cured?” Nutrition Reviews, vol. 65, no. 12, pp. S173–176, 2007. View at Google Scholar · View at Scopus
  36. A. Vojdani, “Antibodies as predictors of complex autoimmune diseases,” International Journal of Immunopathology and Pharmacology, vol. 21, no. 2, pp. 267–278, 2008. View at Google Scholar · View at Scopus
  37. A. Vojdani, M. Bazargan, E. Vojdani et al., “Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 3, pp. 515–524, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Watanabe, T. Yamamoto, M. Yoshida et al., “The traditional herbal medicine saireito exerts its inhibitory effect on murine oxazolone-induced colitis via the induction of Th1-polarized immune responses in the mucosal immune system of the colon,” International Archives of Allergy and Immunology, vol. 151, no. 2, pp. 98–106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Durai, H. R. Kim, K. Bala, and K. D. Moudgil, “T cells against the pathogenic and protective epitopes of heat-shock protein 65 are crossreactive and display functional similarity: novel aspect of regulation of autoimmune arthritis,” Journal of Rheumatology, vol. 34, no. 11, pp. 2134–2143, 2007. View at Google Scholar · View at Scopus
  40. H. R. Kim, R. Rajaiah, Q.-L. Wu et al., “Green tea protects rats against autoimmune arthritis by modulating disease-related immune events,” Journal of Nutrition, vol. 138, no. 11, pp. 2111–2116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Rajaiah, D. Y.-W. Lee, Z. Ma et al., “Huo-Luo-Xiao-Ling Dan modulates antigen-directed immune response in adjuvant-induced inflammation,” Journal of Ethnopharmacology, vol. 123, no. 1, pp. 40–44, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. H. R. Kim, E. Y. Kim, J. Cerny, and K. D. Moudgil, “Antibody responses to mycobacterial and self heat shock protein 65 in autoimmune arthritis: epitope specificity and implication in pathogenesis,” The Journal of Immunology, vol. 177, no. 10, pp. 6634–6641, 2006. View at Google Scholar · View at Scopus
  43. S. Shahrara, A. E. I. Proudfoot, J. M. Woods et al., “Amelioration of rat adjuvant-induced arthritis by Met-RANTES,” Arthritis and Rheumatism, vol. 52, no. 6, pp. 1907–1919, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Y. Mia, E. Y. Kim, S. R. Satpute, and K. D. Moudgil, “The dynamics of articular leukocyte trafficking and the immune response to self heat-shock protein 65 influence arthritis susceptibility,” Journal of Clinical Immunology, vol. 28, no. 5, pp. 420–431, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. M. G. P. Coelho, K. C. C. Sabino, and S. R. Dalmau, “Immunomodulatory effects of sucupira (Pterodon pubescens) seed infusion on collagen-induced arthritis,” Clinical and Experimental Rheumatology, vol. 22, no. 2, pp. 213–218, 2004. View at Google Scholar · View at Scopus
  46. X.-Y. Chen, J. Li, W.-M. Cheng, H. Jiang, X.-F. Xie, and R. Hu, “Effect of total flavonoids of chrysanthemum indicum on the apoptosis of synoviocytes in joint of adjuvant arthritis rats,” American Journal of Chinese Medicine, vol. 36, no. 4, pp. 695–704, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. V. Ramgolam, S. G. Ang, Y. H. Lai, C. S. Loh, and H. K. Yap, “Traditional Chinese medicines as immunosuppressive agents,” Annals of the Academy of Medicine Singapore, vol. 29, no. 1, pp. 11–16, 2000. View at Google Scholar · View at Scopus
  48. A. R. Setty and L. H. Sigal, “Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects,” Seminars in Arthritis and Rheumatism, vol. 34, no. 6, pp. 773–784, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Shen and J.-D. Lu, “Treatment of adjuvant arthritis in rats with Chinese herbal fumigation: efficacy and mechanism,” Journal of Chinese Integrative Medicine, vol. 7, no. 2, pp. 157–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Wang, Y. Dai, J. Yang, G. Chou, C. Wang, and Z. Wang, “Treatment with total alkaloids from Radix Linderae reduces inflammation and joint destruction in type II collagen-induced model for rheumatoid arthritis,” Journal of Ethnopharmacology, vol. 111, no. 2, pp. 322–328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. T.-Y. Wang, J. Li, J.-F. Ge et al., “Preliminary study of total flavonoids from Litsea coreana Levl. on experimental adjuvant-induced arthritis in rats,” American Journal of Chinese Medicine, vol. 36, no. 5, pp. 899–912, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Wang, L. Jia, and C.-Y. Wu, “Triptolide inhibits the differentiation of Th17 cells and suppresses collagen-induced arthritis,” Scandinavian The Journal of Immunology, vol. 68, no. 4, pp. 383–390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Inoue, Y. Ono, and H. Mizukami, “Suppressive effect of dai-bofu-to on collagen-induced arthritis,” Biological and Pharmaceutical Bulletin, vol. 27, no. 6, pp. 857–862, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Niizawa, T. Kogure, L. X. Hai et al., “Clinical and immunomodulatory effects of Fun-boi, an herbal medicine, on collagen-induced arthritis in vivo,” Clinical and Experimental Rheumatology, vol. 21, no. 1, pp. 57–62, 2003. View at Google Scholar · View at Scopus
  55. M. Liu, Y. Dai, X. Yao et al., “Anti-rheumatoid arthritic effect of madecassoside on type II collagen-induced arthritis in mice,” International Immunopharmacology, vol. 8, no. 11, pp. 1561–1566, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. Y.-C. Lee, S.-H. Kim, S.-S. Roh, H.-Y. Choi, and Y.-B. Seo, “Suppressive effects of Chelidonium majus methanol extract in knee joint, regional lymph nodes, and spleen on collagen-induced arthritis in mice,” Journal of Ethnopharmacology, vol. 112, no. 1, pp. 40–48, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Liu, Y. Chen, J. R. Lamb, and P. K. H. Tam, “Triptolide, a component of Chinese herbal medicine, modulates the functional phenotype of dendritic cells,” Transplantation, vol. 84, no. 11, pp. 1517–1526, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Tong and K. D. Moudgil, “Celastrus aculeatus Merr. suppresses the induction and progression of autoimmune arthritis by modulating immune response to heat-shock protein 65,” Arthritis Research and Therapy, vol. 9, no. 4, article R70, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. T. M. Haqqi, D. D. Anthony, S. Gupta et al., “Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 8, pp. 4524–4529, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Shukla, K. Gupta, Z. Rasheed, K. A. Khan, and T. M. Haqqi, “Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis,” Nutrition, vol. 24, no. 7-8, pp. 733–743, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. D.-O. Moon, M.-O. Kim, Y. H. Choi, Y.-M. Park, and G.-Y. Kim, “Curcumin attenuates inflammatory response in IL-1β-induced human synovial fibroblasts and collagen-induced arthritis in mouse model,” International Immunopharmacology, vol. 10, no. 5, pp. 605–610, 2010. View at Publisher · View at Google Scholar
  62. K. R. Patil, C. R. Patil, R. B. Jadhav, V. K. Mahajan, P. R. Patil, and P. S. Gaikwad, “Anti-arthritic Activity of Bartogenic Acid Isolated from Fruits of Barringtonia racemosa Roxb. (Lecythidaceae),” Evidence-Based Complementary and Alternative Medicine. 2009 In press.
  63. E. Brahn, C. Tang, and M. L. Banquerigo, “Regression of collagen-induced arthritis with taxol, a microtubule stabilizer,” Arthritis and Rheumatism, vol. 37, no. 6, pp. 839–845, 1994. View at Publisher · View at Google Scholar · View at Scopus
  64. S. J. Oliver, M. L. Banquerigo, and E. Brahn, “Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, Taxol,” Cellular Immunology, vol. 157, no. 1, pp. 291–299, 1994. View at Publisher · View at Google Scholar · View at Scopus
  65. M. R. Chevrier, A. E. Ryan, D. Y.-W. Lee, M. Zhongze, Z. Wu-Yan, and C. S. Via, “Boswellia carterii extract inhibits TH1 cytokines and promotes TH2 cytokines in vitro,” Clinical and Diagnostic Laboratory Immunology, vol. 12, no. 5, pp. 575–580, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. I. V. Kumar, B. N. Paul, R. Asthana, A. Saxena, S. Mehrotra, and G. Rajan, “Swertia chirayita Mediated Modulation of Interleukin-1β, Interleukin-6, Interleukin-10, Interferon-γ, and Tumor Necrosis Factor-α in Arthritic Mice,” Immunopharmacology and Immunotoxicology, vol. 25, no. 4, pp. 573–583, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. J. L. Funk, J. B. Frye, J. N. Oyarzo, and B. N. Timmermann, “Comparative effects of two gingerol-containing zingiber officinale extracts on experimental Rheumatoid arthritis,” Journal of Natural Products, vol. 72, no. 3, pp. 403–407, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. J.-M. Chang, C.-M. Cheng, L.-M. Hung, Y.-S. Chung, and R.-Y. Wu, “Potential use of plectranthus amboinicus in the treatment of rheumatoid arthritis,” Evidence-Based Complementary and Alternative Medicine, vol. 7, no. 1, pp. 115–120, 2010. View at Publisher · View at Google Scholar
  69. X. Cai, H. Zhou, Y. F. Wong et al., “Suppression of the onset and progression of collagen-induced arthritis in rats by QFGJS, a preparation from an anti-arthritic Chinese herbal formula,” Journal of Ethnopharmacology, vol. 110, no. 1, pp. 39–48, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Y. Fan, L. Lao, R. X. Zhang et al., “Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on adjuvant-induced arthritis in lewis rats,” Journal of Ethnopharmacology, vol. 101, no. 1–3, pp. 104–109, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. Y.-H. He, C. Xiao, Y.-S. Wang et al., “Antioxidant and anti-inflammatory effects of cyanidin from cherries on rat adjuvant-induced arthritis,” Zhongguo Zhongyao Zazhi, vol. 30, no. 20, pp. 1602–1605, 2005. View at Google Scholar · View at Scopus
  72. H.-M. Xu, W. Wei, X.-Y. Jia, Y. Chang, and L. Zhang, “Effects and mechanisms of total glucosides of paeony on adjuvant arthritis in rats,” Journal of Ethnopharmacology, vol. 109, no. 3, pp. 442–448, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. D.-S. Yang, F. Liu, F.-D. Zeng, and H. Chen, “Effect of sinomenine on adjuvant arthritis and its mechanisms,” Zhongguo Zhongyao Zazhi, vol. 30, no. 17, pp. 1361–1363, 2005. View at Google Scholar · View at Scopus
  74. L. Zhang, J. Li, S.-C. Yu et al., “Therapeutic effects and mechanisms of total flavonoids of Turpinia Arguta Seen on adjuvant arthritis in rats,” Journal of Ethnopharmacology, vol. 116, no. 1, pp. 167–172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. R.-X. Zhang, A. Y. Fan, A.-N. Zhou et al., “Extract of the Chinese herbal formula Huo Luo Xiao Ling Dan inhibited adjuvant arthritis in rats,” Journal of Ethnopharmacology, vol. 121, no. 3, pp. 366–371, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. K.-S. Kim, S.-D. Lee, K.-H. Kim, S.-Y. Kil, K.-H. Chung, and C.-H. Kim, “Suppressive effects of a water extract of Ulmus davidiana Planch (Ulmaceae) on collagen-induced arthritis in mice,” Journal of Ethnopharmacology, vol. 97, no. 1, pp. 65–71, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. S. S. Shin, M. Jin, H. J. Jung et al., “Suppressive effects of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice,” Rheumatology, vol. 42, no. 5, pp. 665–672, 2003. View at Google Scholar · View at Scopus
  78. J. L. Funk, J. N. Oyarzo, J. B. Frye et al., “Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis,” Journal of Natural Products, vol. 69, no. 3, pp. 351–355, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. J. L. Funk, J. B. Frye, J. N. Oyarzo et al., “Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis,” Arthritis and Rheumatism, vol. 54, no. 11, pp. 3452–3464, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. F. Wei, S. Zou, A. Young, R. Dubner, and K. Ren, “Effects of four herbal extracts on adjuvant-induced inflammation and hyperalgesia in rats,” Journal of Alternative and Complementary Medicine, vol. 5, no. 5, pp. 429–436, 1999. View at Google Scholar · View at Scopus
  81. P. Prakash and N. Gupta, “Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: a short review,” Indian Journal of Physiology and Pharmacology, vol. 49, no. 2, pp. 125–131, 2005. View at Google Scholar · View at Scopus
  82. G. S. Thakur, M. Bag, B. S. Sanodiya et al., “Chlorophytum borivilianum: a white gold for biopharmaceuticals and neutraceuticals,” Current Pharmaceutical Biotechnology, vol. 10, no. 7, pp. 650–666, 2009. View at Publisher · View at Google Scholar
  83. S. Kanai, N. Taniguchi, and H. Higashino, “Study of Sokei-Kakketu-To (Shu-Jing-Huo-Xue-Tang) in adjuvant arthritis rats,” American Journal of Chinese Medicine, vol. 31, no. 6, pp. 879–884, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. R. C. Lawrence, C. G. Helmick, F. C. Arnett et al., “Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States,” Arthritis and Rheumatism, vol. 41, no. 5, pp. 778–799, 1998. View at Publisher · View at Google Scholar · View at Scopus
  85. C. L. Gorman and A. P. Cope, “Immune-mediated pathways in chronic inflammatory arthritis,” Best Practice and Research, vol. 22, no. 2, pp. 221–238, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. K. Aho, M. Koskenvuo, J. Tuominen, and J. Kaprio, “Occurrence of rheumatoid arthritis in a nationwide series of twins,” Journal of Rheumatology, vol. 13, no. 5, pp. 899–902, 1986. View at Google Scholar · View at Scopus
  87. C. M. Pearson, “Development of arthritis, periarthritis and periostitis in rats given adjuvants,” Proceedings of the Society for Experimental Biology and Medicine, vol. 91, no. 1, pp. 95–101, 1956. View at Google Scholar
  88. W. V. Eden, J. E. R. Thole, R. V. D. Zee et al., “Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis,” Nature, vol. 331, no. 6152, pp. 171–173, 1988. View at Google Scholar · View at Scopus
  89. K. D. Moudgil, T. T. Chang, H. Eradat et al., “Diversification of T cell responses to carboxy-terminal determinants within the 65-kD heat-shock protein is involved in regulation of autoimmune arthritis,” Journal of Experimental Medicine, vol. 185, no. 7, pp. 1307–1316, 1997. View at Publisher · View at Google Scholar · View at Scopus
  90. C.-L. Shen, J. K. Yeh, J. J. Cao, O. L. Tatum, R. Y. Dagda, and J.-S. Wang, “Synergistic effects of green tea polyphenols and alphacalcidol on chronic inflammation-induced bone loss in female rats,” Osteoporosis International, vol. 11, pp. 1841–1852, 2010. View at Publisher · View at Google Scholar
  91. C.-L. Shen, J. K. Yeh, J. J. Cao, O. L. Tatum, R. Y. Dagda, and J.-S. Wang, “Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation-induced bone loss model,” Journal of Nutritional Biochemistry, vol. 21, no. 10, pp. 968–974, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. R. Rajaiah and K. D. Moudgil, “Heat-shock proteins can promote as well as regulate autoimmunity,” Autoimmunity Reviews, vol. 8, no. 5, pp. 388–393, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. M. Durai, R. S. Gupta, and K. D. Moudgil, “The T Cells Specific for the Carboxyl-Terminal Determinants of Self (Rat) Heat-Shock Protein 65 Escape Tolerance Induction and Are Involved in Regulation of Autoimmune Arthritis,” The Journal of Immunology, vol. 172, no. 5, pp. 2795–2802, 2004. View at Google Scholar · View at Scopus
  94. M. G. Danieli, D. Markovits, A. Gabrielli et al., “Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein,” Clinical Immunology and Immunopathology, vol. 64, no. 2, pp. 121–128, 1992. View at Publisher · View at Google Scholar · View at Scopus
  95. E. R. De Graeff-Meeder, R. Van der Zee, G. T. Rijkers et al., “Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis,” The Lancet, vol. 337, no. 8754, pp. 1368–1372, 1991. View at Publisher · View at Google Scholar · View at Scopus
  96. P. C. M. Res, F. C. Breedveld, J. D. A. van Embden et al., “Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis,” The Lancet, vol. 2, no. 8609, pp. 478–480, 1988. View at Google Scholar · View at Scopus
  97. T. Miletić, V. Kovačević-Jovanović, S. Stanojević et al., “Strain differences and the role for HSP47 and HSP70 in adjuvant arthritis in rats,” Scandinavian The Journal of Immunology, vol. 64, no. 6, pp. 623–632, 2006. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Morino, T. Tsuzuki, Y. Ishikawa et al., “Specific regulation of HSPs in human tumor cell lines by flavonoids,” In Vivo, vol. 11, no. 3, pp. 265–270, 1997. View at Google Scholar · View at Scopus
  99. A. M. Chow and I. R. Brown, “Induction of heat shock proteins in differentiated human and rodent neurons by celastrol,” Cell Stress and Chaperones, vol. 12, no. 3, pp. 237–244, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. S. D. Westerheide, J. D. Bosman, B. N. A. Mbadugha et al., “Celastrols as inducers of the heat shock response and cytoprotection,” The Journal of Biological Chemistry, vol. 279, no. 53, pp. 56053–56060, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. C. Billard, J.-C. Izard, V. Roman et al., “Comparative antiproliferative and apoptotic effects of resveratrol, ε-viniferin and vine-shots derived polyphenols (Vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes,” Leukemia and Lymphoma, vol. 43, no. 10, pp. 1991–2002, 2002. View at Publisher · View at Google Scholar · View at Scopus
  102. E. Lugli, R. Ferraresi, E. Roat et al., “Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells,” Leukemia Research, vol. 33, no. 1, pp. 140–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. S. J. Zunino and D. H. Storms, “Resveratrol alters proliferative responses and apoptosis in human activated B lymphocytes in vitro,” Journal of Nutrition, vol. 139, no. 8, pp. 1603–1608, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. C. Filippi, D. Bresson, and M. von Herrath, “Antigen-specific induction of regulatory T cells for type 1 diabetes therapy,” International Reviews of Immunology, vol. 24, no. 5-6, pp. 341–360, 2005. View at Publisher · View at Google Scholar · View at Scopus
  105. S. Sakaguchi, N. Sakaguchi, J. Shimizu et al., “Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance,” Immunological Reviews, vol. 182, pp. 18–32, 2001. View at Publisher · View at Google Scholar · View at Scopus
  106. J. A. Bluestone and A. K. Abbas, “Natural versus adaptive regulatory T cells,” Nature Reviews Immunology, vol. 3, no. 3, pp. 253–257, 2003. View at Publisher · View at Google Scholar · View at Scopus
  107. E. M. Shevach, “Regulatory/suppressor T cells in health and disease,” Arthritis and Rheumatism, vol. 50, no. 9, pp. 2721–2724, 2004. View at Publisher · View at Google Scholar · View at Scopus
  108. O. Frey, P. K. Petrow, M. Gajda et al., “The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells,” Arthritis Research & Therapy, vol. 7, no. 2, pp. R291–301, 2005. View at Google Scholar · View at Scopus
  109. M. E. Morgan, R. P. M. Sutmuller, H. J. Witteveen et al., “CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis,” Arthritis and Rheumatism, vol. 48, no. 5, pp. 1452–1460, 2003. View at Publisher · View at Google Scholar · View at Scopus
  110. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  111. A. Vojdani and J. Erde, “Regulatory T cells, a potent immunoregulatory target for CAM researchers: modulating tumor immunity, autoimmunity and alloreactive immunity (III),” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 3, pp. 309–316, 2006. View at Publisher · View at Google Scholar · View at Scopus
  112. M. R. Ehrenstein, J. G. Evans, A. Singh et al., “Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy,” Journal of Experimental Medicine, vol. 200, no. 3, pp. 277–285, 2004. View at Publisher · View at Google Scholar · View at Scopus
  113. A.-S. Korganow, J. Hong, S. Mangialaio et al., “From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins,” Immunity, vol. 10, no. 4, pp. 451–461, 1999. View at Publisher · View at Google Scholar · View at Scopus
  114. M. A. Cremer, A. S. Townes, and A. H. Kang, “Collagen-induced arthritis in rodents. A review of clinical, histological and immunological features,” Ryumachi, vol. 24, no. 1, pp. 45–56, 1984. View at Google Scholar · View at Scopus
  115. R. Ulmansky, C. J. Cohen, F. Szafer et al., “Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion,” The Journal of Immunology, vol. 168, no. 12, pp. 6463–6469, 2002. View at Google Scholar · View at Scopus
  116. M. Feldmann, F. M. Brennan, B. M. Foxwell, and R. N. Maini, “The role of TNF alpha and IL-1 in rheumatoid arthritis,” Current directions in autoimmunity, vol. 3, pp. 188–199, 2001. View at Google Scholar · View at Scopus
  117. L. B. Ivashkiv, “Cytokine expression and cell activation in inflammatory arthritis,” Advances in Immunology, vol. 63, pp. 337–376, 1996. View at Google Scholar · View at Scopus
  118. T. Forsthuber, H. C. Yip, and P. V. Lehmann, “Induction of TH1 and TH2 immunity in neonatal mice,” Science, vol. 271, no. 5256, pp. 1728–1730, 1996. View at Google Scholar · View at Scopus
  119. D. B. Stevens, D. P. Gold, E. E. Sercarz, and K. D. Moudgil, “The Wistar Kyoto (RT1l) rat is resistant to myelin basic protein-induced experimental autoimmune encephalomyelitis: comparison with the susceptible Lewis (RT1l) strain with regard to the MBP-directed CD4+ T cell repertoire and its regulation,” Journal of Neuroimmunology, vol. 126, no. 1-2, pp. 25–36, 2002. View at Publisher · View at Google Scholar · View at Scopus
  120. U. Christen and M. G. Von Herrath, “Manipulating the type 1 vs type 2 balance in type 1 diabetes,” Immunologic Research, vol. 30, no. 3, pp. 309–325, 2004. View at Publisher · View at Google Scholar · View at Scopus
  121. C. Mauri, M. Feldmann, and R. O. Williams, “Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response,” Arthritis and Rheumatism, vol. 48, no. 3, pp. 839–845, 2003. View at Publisher · View at Google Scholar · View at Scopus
  122. S.-C. Chun, S. Y. Jee, S. G. Lee, S. J. Park, J. R. Lee, and S. C. Kim, “Anti-inflammatory activity of the methanol extract of Moutan Cortex in LPS-activated Raw264.7 cells,” Evidence-Based Complementary and Alternative Medicine, vol. 4, no. 3, pp. 327–333, 2007. View at Publisher · View at Google Scholar · View at Scopus
  123. E. Y. Kim and K. D. Moudgil, “Regulation of autoimmune inflammation by pro-inflammatory cytokines,” Immunology Letters, vol. 120, no. 1-2, pp. 1–5, 2008. View at Publisher · View at Google Scholar · View at Scopus
  124. A. Vojdani and J. Lambert, “The role of Th17 in neuroimmune disorders: target for CAM therapy. Part I,” Evidence-Based Complementary and Alternative Medicine. 2009 In press.
  125. M. Ziolkowska, A. Koc, G. Luszczykiewicz et al., “High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism,” The Journal of Immunology, vol. 164, no. 5, pp. 2832–2838, 2000. View at Google Scholar · View at Scopus
  126. E. Lubberts, M. I. Koenders, B. Oppers-Walgreen et al., “Treatment with a Neutralizing Anti-Murine Interleukin-17 Antibody after the Onset of Collagen-Induced Arthritis Reduces Joint Inflammation, Cartilage Destruction, and Bone Erosion,” Arthritis and Rheumatism, vol. 50, no. 2, pp. 650–659, 2004. View at Publisher · View at Google Scholar · View at Scopus
  127. S. Nakae, A. Nambu, K. Sudo, and Y. Iwakura, “Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice,” The Journal of Immunology, vol. 171, no. 11, pp. 6173–6177, 2003. View at Google Scholar · View at Scopus
  128. M. I. Koenders, J. K. Kolls, B. Oppers-Walgreen et al., “Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis,” Arthritis and Rheumatism, vol. 52, no. 10, pp. 3239–3247, 2005. View at Publisher · View at Google Scholar · View at Scopus
  129. T. Kasama, R. M. Strieter, N. W. Lukacs, P. M. Lincoln, M. D. Burdick, and S. L. Kunkel, “Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis,” The Journal of Clinical Investigation, vol. 95, no. 6, pp. 2868–2876, 1995. View at Google Scholar · View at Scopus
  130. M. M. Halloran, Z. Szekanecz, N. Barquin, G. K. Haines, and A. E. Koch, “Cellular adhesion molecules in rat adjuvant arthritis,” Arthritis and Rheumatism, vol. 39, no. 5, pp. 810–819, 1996. View at Publisher · View at Google Scholar · View at Scopus
  131. H. Okamoto and N. Kamatani, “A CCR-5 antagonist inhibits the development of adjuvant arthritis in rats,” Rheumatology, vol. 45, no. 2, pp. 230–232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  132. D. A. Barnes, J. Tse, M. Kaufhold et al., “Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model,” The Journal of Clinical Investigation, vol. 101, no. 12, pp. 2910–2919, 1998. View at Google Scholar · View at Scopus
  133. X. Chen, J. J. Oppenheim, and O. M. Howard, “Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components,” Cellular & Molecular Immunology, vol. 1, no. 5, pp. 336–342, 2004. View at Google Scholar · View at Scopus
  134. T. Nanki, T. Shimaoka, K. Hayashida, K. Taniguchi, S. Yonehara, and N. Miyasaka, “Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 52, no. 10, pp. 3004–3014, 2005. View at Publisher · View at Google Scholar · View at Scopus
  135. H.-S. Cui, S. Hayasaka, X.-Y. Zhang, Y. Hayasaka, Z.-L. Chi, and L.-S. Zheng, “Effect of berberine on interleukin 8 and monocyte chemotactic protein 1 expression in a human retinal pigment epithelial cell line,” Ophthalmic Research, vol. 38, no. 3, pp. 149–157, 2006. View at Publisher · View at Google Scholar · View at Scopus
  136. B. Jayaprakasam, S. Doddaga, R. Wang, D. Holmes, J. Goldfarb, and X.-M. Li, “Licorice flavonoids inhibit eotaxin-1 secretion by human fetal lung fibroblasts in vitro,” Journal of Agricultural and Food Chemistry, vol. 57, no. 3, pp. 820–825, 2009. View at Publisher · View at Google Scholar · View at Scopus
  137. J. S. Lee, S. Y. Park, D. Thapa, A. R. Kim, H. M. Shin, and J. A. Kim, “HMC05, herbal formula, inhibits TNF-{alpha}-induced inflammatory response in human umbilical vein endothelial cells,” Evidence-Based Complementary and Alternative Medicine. 2009 In press.
  138. K.-H. Lee, M.-H. Yeh, S.-T. Kao et al., “Xia-Bai-San inhibits lipopolysaccharide-induced activation of intercellular adhesion molecule-1 and nuclear factor-kappa B in human lung cells,” Journal of Ethnopharmacology, vol. 124, no. 3, pp. 530–538, 2009. View at Publisher · View at Google Scholar · View at Scopus
  139. N.-K. Mak, C.-Y. Leung, X.-Y. Wei et al., “Inhibition of RANTES expression by indirubin in influenza virus-infected human bronchial epithelial cells,” Biochemical Pharmacology, vol. 67, no. 1, pp. 167–174, 2004. View at Publisher · View at Google Scholar · View at Scopus
  140. M. K. Moon, Y. J. Lee, J. S. Kim, D. G. Kang, and H. S. Lee, “Effect of caffeic acid on tumor necrosis factor-alpha-induced vascular inflammation in human umbilical vein endothelial cells,” Biological and Pharmaceutical Bulletin, vol. 32, no. 8, pp. 1371–1377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  141. M.-H. Yang, F.-X. Wu, C.-M. Xie et al., “Expression of CC chemokine ligand 5 in patients with rheumatoid arthritis and its correlation with disease activity and medication,” Chinese Medical Sciences Journal, vol. 24, no. 1, pp. 50–54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  142. S. F. H. Zaidi, K. Ahmed, T. Yamamoto et al., “Effect of resveratrol on Helicobacter pylori-induced interleukin-8 secretion, reactive oxygen species generation and morphological changes in human gastric epithelial cells,” Biological and Pharmaceutical Bulletin, vol. 32, no. 11, pp. 1931–1935, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. S. Chittur, B. Parr, and G. Marcovici, “Inhibition of inflammatory gene expression in keratinocytes using a composition containing carnitine, thioctic acid and saw palmetto extract,” Evidence-Based Complementary and Alternative Medicine. 2009 In press.
  144. S. Katz, R. Harris, J. T.-Y. Lau, and A. Chau, “The use of gene expression analysis and proteomic databases in the development of a screening system to determine the value of natural medicinal products,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 1, pp. 65–70, 2006. View at Publisher · View at Google Scholar · View at Scopus
  145. C. Matsumoto, T. Kojima, K. Ogawa et al., “A proteomic approach for the diagnosis of 'Oketsu' (blood stasis), a pathophysiologic concept of Japanese traditional (Kampo) medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 4, pp. 463–474, 2008. View at Publisher · View at Google Scholar · View at Scopus